HEATHER POLASKI: Open Payments
NPI 1053665372 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 16 payments from 10 companies in 2025. Trend: 2023 $186 · 2024 $237 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $284 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| Axsome Therapeutics, Inc. | 1 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Alkermes, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Corium, LLC | 1 | $6 |
Products named: VRAYLAR, COBENFY, Auvelity, ARISTADA, INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
